Literature DB >> 21738289

The AmBulatory Closure Device Percutaneous Intervention (ABCD-PCI) study: a single-center experience.

Adam M Falcone1, Rahul Bose, Robert C Stoler, Michael Kim, Emily Laible, Lucy Kang, Kim Waters, Janet Dunkerley, James W Choi.   

Abstract

The AmBulatory Closure Device Percutaneous Intervention (ABCD-PCI) study is a multicenter randomized prospective controlled trial evaluating the safety of and patient satisfaction with same-day discharge following ambulatory percutaneous intervention with a closure device. This article reviews the findings from a single center, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, from October 2008 through April 2010, with 23 patients in the same-day discharge group and 21 patients in the next-day discharge group. There were no differences between the groups in demographic or procedure characteristics. Outcomes were measured by a questionnaire and 7-day and 30-day follow-up phone calls. Results showed that same-day discharge after percutaneous intervention with a closure device is as safe as next-day discharge. However, there was a trend for a higher comfort level among patients in the next-day discharge group.

Entities:  

Year:  2011        PMID: 21738289      PMCID: PMC3124901          DOI: 10.1080/08998280.2011.11928713

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  6 in total

1.  Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials.

Authors:  D S Baim; W D Knopf; T Hinohara; D E Schwarten; R A Schatz; C A Pinkerton; D E Cutlip; M Fitzpatrick; K K Ho; R E Kuntz
Journal:  Am J Cardiol       Date:  2000-04-01       Impact factor: 2.778

2.  Effectiveness and complications of vascular access closure devices after interventional procedures.

Authors:  M Sesana; M Vaghetti; R Albiero; N Corvaja; G Martini; G Sivieri; A Colombo
Journal:  J Invasive Cardiol       Date:  2000-08       Impact factor: 2.022

3.  A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation.

Authors:  Olivier F Bertrand; Robert De Larochellière; Josep Rodés-Cabau; Guy Proulx; Onil Gleeton; Can Manh Nguyen; Jean-Pierre Déry; Gérald Barbeau; Bernard Noël; Eric Larose; Paul Poirier; Louis Roy
Journal:  Circulation       Date:  2006-12-04       Impact factor: 29.690

4.  Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.

Authors:  A Michael Lincoff; John A Bittl; Robert A Harrington; Frederick Feit; Neal S Kleiman; J Daniel Jackman; Ian J Sarembock; David J Cohen; Douglas Spriggs; Ramin Ebrahimi; Gadi Keren; Jeffrey Carr; Eric A Cohen; Amadeo Betriu; Walter Desmet; Dean J Kereiakes; Wolfgang Rutsch; Robert G Wilcox; Pim J de Feyter; Alec Vahanian; Eric J Topol
Journal:  JAMA       Date:  2003-02-19       Impact factor: 56.272

5.  Bivalirudin during primary PCI in acute myocardial infarction.

Authors:  Gregg W Stone; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; Franz Hartmann; Bernard J Gersh; Stuart J Pocock; George Dangas; S Chiu Wong; Ajay J Kirtane; Helen Parise; Roxana Mehran
Journal:  N Engl J Med       Date:  2008-05-22       Impact factor: 91.245

6.  Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS).

Authors:  Gerlind S Heyde; Karel T Koch; Robbert J de Winter; Marcel G W Dijkgraaf; Margriet I Klees; Lea M Dijksman; Jan J Piek; Jan G P Tijssen
Journal:  Circulation       Date:  2007-04-09       Impact factor: 29.690

  6 in total
  4 in total

Review 1.  Same Day Discharge versus Overnight Stay in the Hospital following Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Pravesh Kumar Bundhun; Mohammad Zafooruddin Sani Soogund; Wei-Qiang Huang
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

Review 2.  Early discharge compared with ordinary discharge after percutaneous coronary intervention - a systematic review and meta-analysis of safety and cost.

Authors:  Michael Abdelnoor; Jack Gunnar Andersen; Harald Arnesen; Odd Johansen
Journal:  Vasc Health Risk Manag       Date:  2017-03-20

3.  Novel Patient-Centered Approach to Facilitate Same-Day Discharge in Patients Undergoing Elective Percutaneous Coronary Intervention.

Authors:  Amit P Amin; Patricia Crimmins-Reda; Samantha Miller; Brandon Rahn; Mary Caruso; Andrew Pierce; Brandy Dennis; Marissa Pendegraft; Katrine Sorensen; Howard I Kurz; John M Lasala; Alan Zajarias; Richard G Bach; Hemant Kulkarni; Jasvindar Singh
Journal:  J Am Heart Assoc       Date:  2018-02-15       Impact factor: 5.501

4.  Enhancing Outcomes for Outpatient Percutaneous Coronary Interventions.

Authors:  Kevin Spruce; Chondra Butler
Journal:  Clin Nurse Spec       Date:  2017 Nov/Dec       Impact factor: 1.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.